美股异动 | 获礼来收购预期升温 Abivax(ABVX.US)开盘大涨逼近历史新高

Core Viewpoint - Abivax S.A. (ABVX.US) experienced a nearly 15% surge in stock price, approaching its historical high, following reports of potential acquisition discussions with Eli Lilly [1] Group 1: Company Developments - Eli Lilly has initiated preliminary discussions with French authorities regarding a possible acquisition of the biotechnology company Abivax [1] - The discussions included a meeting with the French Ministry of Finance in early December to assess any foreign investment review restrictions that may apply to the acquisition [1] - Eli Lilly also explored the involvement of state investor Bpifrance as a minority shareholder in the potential acquisition [1]